Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Varian, a Siemens Healthineers Company
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Wake Forest University Health Sciences
University Hospitals Coventry and Warwickshire NHS Trust
Instituto Nacional de Cancerologia de Mexico
Memorial Sloan Kettering Cancer Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Wake Forest University Health Sciences
Intuitive Surgical
University of Oklahoma
Massachusetts General Hospital
Massachusetts General Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
Centre Jean Perrin
Centre hospitalier de l'Université de Montréal (CHUM)
Abramson Cancer Center at Penn Medicine
Pusan National University Hospital
University of California, Davis
M.D. Anderson Cancer Center
University Hospital Heidelberg
University Health Network, Toronto
University of Kentucky
University Health Network, Toronto
Abramson Cancer Center at Penn Medicine
Istituto Oncologico Veneto IRCCS
Jonsson Comprehensive Cancer Center
Carevive Systems, Inc.
University of Pennsylvania
City of Hope Medical Center
Duke University
VA Office of Research and Development
Ohio State University Comprehensive Cancer Center
Royal North Shore Hospital
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Abramson Cancer Center at Penn Medicine
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Wake Forest University Health Sciences
Boehringer Ingelheim
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
M.D. Anderson Cancer Center
Kaiser Permanente
Intuitive Surgical
University of Colorado, Denver
Istanbul University